Companies · Other Health Care

KleenGel, LLC

BOCA RATON · Other Health Care

Diligence memoA one-page analyst read on KleenGel, LLC — recommendation, valuation, rhythm, risks.
$465K
Total raised · real
3
Rounds
2.0×
Latest step-up
Top 82%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

KleenGel, LLC looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.76× the median modeled value of Pre-Seed Other Health Care companies in 2019–2021 (295 peers) — value vs value, same stage and era.
  • Within the normal band (76% of peer median) for its niche.
Dormant
  • Last raise 6.1 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

KleenGel, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
13.7 yr record
Peak capital year was 2020 with $200K across 1 filings.
Market position
ahead of 19% of Other Health Care peers
Capital scale is ahead of 19% of Other Health Care peers; modeled value is above 26% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2020: $200K across 1 filings.
  • Largest single filing was $200K on 2020-05-18.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

KleenGel, LLC is one of 5376 Other Health Care companies tracked from BOCA RATON. By capital raised it ranks in the long tail (ahead of 19% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2020-05-18
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$2.5M$5.0M$7.5M$10MPre-Seed · 2012-10-31 Raised $165K (real) Modeled valuation $5.1M (est)$165K$5.1MPre-Seed2012Pre-Seed · 2014-12-29 Raised $100K (real) Modeled valuation $3.1M (est)$100K$3.1MPre-Seed2014Pre-Seed · 2020-05-18 Raised $200K (real) Modeled valuation $6.2M (est)$200K$6.2MPre-Seed2020+$100K+$200KCumulative $465K

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$165K · 2012
Pre-Seed extension$100K · 2014
Pre-Seed extension$200K · 2020

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$6.2M
Base estimate est.
$125K
Conservative case
$69.9M
Upside case
$1.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $5.1M · 2012-10-312012Pre-Seed · modeled $3.1M · 2014-12-29Pre-Seed · modeled $6.2M · 2020-05-182020
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
6.0 yr
Elapsed time used
6.1 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
45 mo
Avg between rounds
$62K/yr
Capital velocity
13.7 yr
On record since
2012
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.2× of median
This company$465K
Sector median$2.4M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 0.6× of median
This company$200K
Sector median$350K
Modeled value — vs sector median (estimate, all stages) 0.3× of median
This company$6.2M
Sector median$22.1M

Raised more than 19% of sector peers (real $). Modeled value above 26% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #179 of 295.

This companyCohort peer
$1.0M$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Aetas Co LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)Hauppauge SC Holdings, LLC · Pre-Seed Raised $995K · modeled $30.6M (est)Gateway IV Lithotripsy, LLC · Pre-Seed Raised $988K · modeled $30.4M (est)Endoscopy Center of West Central Ohio, LLC · Pre-Seed Raised $964K · modeled $29.7M (est)Dalent LLC · Pre-Seed Raised $1.9M · modeled $29.2M (est)FK Investor LLC · Pre-Seed Raised $940K · modeled $29.0M (est)Lynx Dx, Inc. · Pre-Seed Raised $925K · modeled $28.5M (est)Center at Arrowhead, LLC · Pre-Seed Raised $918K · modeled $28.3M (est)MedTek Valencia eCoin, LLC · Pre-Seed Raised $905K · modeled $27.9M (est)Westside PetWell, LLC · Pre-Seed Raised $900K · modeled $27.7M (est)Ulster Dialysis Partners, LLC · Pre-Seed Raised $930K · modeled $27.6M (est)DoveMed, Ltd. · Pre-Seed Raised $1.5M · modeled $26.5M (est)KleenGel, LLC (this company) Raised $465K · modeled $6.2M (est)KleenGel, LLC
CompanyStageRaised · realValue · estvs peer med.
Aetas Co LLCPre-Seed$1.0M$30.8M3.80×
Hauppauge SC Holdings, LLCPre-Seed$995K$30.6M3.78×
Gateway IV Lithotripsy, LLCPre-Seed$988K$30.4M3.76×
Endoscopy Center of West Central Ohio, LLCPre-Seed$964K$29.7M3.67×
Dalent LLCPre-Seed$1.9M$29.2M3.61×
FK Investor LLCPre-Seed$940K$29.0M3.58×
Lynx Dx, Inc.Pre-Seed$925K$28.5M3.52×
Center at Arrowhead, LLCPre-Seed$918K$28.3M3.49×
MedTek Valencia eCoin, LLCPre-Seed$905K$27.9M3.44×
Westside PetWell, LLCPre-Seed$900K$27.7M3.42×
Ulster Dialysis Partners, LLCPre-Seed$930K$27.6M3.40×
DoveMed, Ltd.Pre-Seed$1.5M$26.5M3.28×
KleenGel, LLC this companyPre-Seed$465K$6.2M0.76×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$165K2012-10-31$917K$5.1M85%
Pre-Seed$100K2014-12-29$556K$3.1M85%
Pre-Seed$200K2020-05-18$1.1M$6.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$165K2012-10-31
    • First recorded raise — entered as Pre-Seed.
    • 4 investors on this round.
  2. Pre-Seed$100K2014-12-29
    • Raised again after 26 mo — slower than the ~14 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 06).
    • 2 investors on this round.
  3. Pre-Seed$200K2020-05-18
    • Raised again after 65 mo — slower than the ~14 mo sector norm.
    • Round 2.0× larger than the prior — scaling up.
    • 1 investor on this round.
Intelligence
2024 ~Q1
Modeled next raise · ~45mo cadence
$400K
Modeled next size est.range $260K$640K
2.0×
Last step-up
$62K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Navroze Mehta7 other2012-10
Hans Hickler4 other2014-12
Jonathan Mirabito1 other2014-12
Registry & provenance

KleenGel, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1577042
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
AppwoRx, LLCOther Health CarePre-Seed$225K$6.9Mnetwork2 shared operators · same sector · same stage
ClearSpec, LLCOtherPre-Seed$910K$5.8Mnetwork3 shared operators · same stage
VenX, LLCOther Health CareSeed$3.7M$10.3Mnetwork2 shared operators · same sector
Imagen Littlefield Support Services, LLCOther Health CarePre-Seed$471K$5.6Msame sector · same stage
Imagen Hart Support Services, LLCOther Health CarePre-Seed$457K$5.3Msame sector · same stage
Santa Rosa Surgery Center LpOther Health CarePre-Seed$453K$6.4Msame sector · same stage
Barriere Inc.Other Health CarePre-Seed$450K$6.8Msame sector · same stage
Southwest Stone Center, LlcOther Health CarePre-Seed$493K$7.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Asymmetrix Capital, LLCOther Health CareSeed$14.5M83%
K-Icon, LlcOther Health CarePre-Seed$3.5M83%
Akicept, LlcOther Health CarePre-Seed$2.1M82%
SonerMed, LLCOther Health CareSeries D+$6.7B82%
Hopebridge, LLCOther Health CareSeries B$498.5M82%
Skelo Wear, LLCOther Health CarePre-Seed$562K82%
HeartBeam, Inc.Other Health CarePre-Seed$6.2M82%
K Health, Inc.HealthtechSeries D+$915.1M82%
Frequently asked
How much funding has KleenGel, LLC raised?
KleenGel, LLC has raised approximately $465K in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is KleenGel, LLC's estimated valuation?
Provath's modeled valuation for KleenGel, LLC is approximately $6.2M (modeled range $125K–$69.9M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is KleenGel, LLC at?
KleenGel, LLC's latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Mon May 18.
What does KleenGel, LLC do and where is it based?
KleenGel, LLC operates in the Other Health Care sector, based in BOCA RATON.
Explore related

See where KleenGel, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at KleenGel, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.